CCL17 and toxic epidermal necrolysis: Ogawa’s study revealed a significant increase in serum thymus and activation-regulated chemokine (TARC/CCL17) levels among patients with DRESS compared to those with morbilliform drug eruption and Stevens-Johnson syndrome/Toxic epidermal necrolysis (SJS/TEN) (55).